As Roswell Park Comprehensive Cancer Center continues to utilize the latest immunotherapies that spell hope for so many of our patients, BlueCross BlueShield of Western New York has recognized us as a Blue Distinction Center for Cellular Immunotherapy — CAR-T (chimeric antigen receptor). The center is one of two to receive this distinction in New York State.

Generous donations have set in motion eight groundbreaking new research projects at Roswell Park Comprehensive Cancer Center. The promising preliminary studies received a total of $772,330 from the Roswell Park Alliance Foundation, the 501(c)(3) not-for-profit organization that raises funds and manages all donations made to Roswell Park.

Breast cancer patients who take the dietary supplements known as antioxidants, as well as iron, vitamin B12, and omega-3 fatty acids, during chemotherapy may be at increased risk of disease recurrence and death, according to new study results appearing in the Journal of Clinical Oncology.